# Observational Non-interventional Study With Viramune® in Combination With Truvada® in HIV-infected Patients

> **NCT00543803** · — · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 334 (actual)

## Conditions studied

- HIV Infections

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00543803
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-02
- **Primary completion:** 2009-12
- **Final completion:** —
- **Target enrollment:** 334 (ACTUAL)
- **Last updated:** 2014-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00543803

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00543803, "Observational Non-interventional Study With Viramune® in Combination With Truvada® in HIV-infected Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00543803. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*